Q2 2015 Holdings
Filed 2015-08-14 | 80 holdings | $78.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ardelyx Inc(ARDX) | COM | 039697107 | $23.7M | 1,481,075 | 30.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $16.8M | 140,000 | 21.3% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $16.4M | 569,130 | 20.9% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $10.2M | 680,000 | 12.9% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $8.0M | 450,000 | 10.2% |
| Ascendis Pharma A S(ASND) | SPNSORED ADR | 04351P101 | $1.1M | 61,500 | 1.4% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $1.0M | 100,300 | 1.3% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $458.0K | 25,000 | 0.6% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $408.0K | 11,300 | 0.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $45.0K | 700,000 | 0.1% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $44.9K | 1,440,000 | 0.1% |
| Receptos Inc | COM | 756207106 | $41.8K | 220,000 | 0.1% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $40.1K | 757,475 | 0.1% |
| Dyax Corp | COM | 26746E103 | $37.1K | 1,400,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $34.3K | 718,900 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $34.3K | 1,945,334 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $24.3K | 300,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $22.8K | 500,000 | 0.0% |
| Novavax Inc | COM | 670002104 | $17.8K | 1,600,000 | 0.0% |
| Tesaro Inc | COM | 881569107 | $17.1K | 291,250 | 0.0% |
| Quotient LTD | SHS | G73268107 | $16.6K | 1,119,100 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $16.3K | 800,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $13.5K | 1,559,000 | 0.0% |
| China Biologic Prods Inc | COM | 16938C106 | $12.8K | 111,500 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $12.2K | 153,000 | 0.0% |
| Pfenex Inc | COM | 717071104 | $12.1K | 624,900 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $11.7K | 500,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $11.2K | 208,500 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $10.4K | 102,000 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $10.1K | 780,000 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $9.8K | 896,522 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $9.7K | 255,000 | 0.0% |
| Curis Inc | COM | 231269101 | $8.7K | 2,632,000 | 0.0% |
| Keryx Biopharmaceuticals Inc | COM | 492515101 | $8.2K | 826,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $8.2K | 300,987 | 0.0% |
| Ovascience Inc | COM | 69014Q101 | $7.3K | 252,180 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $7.0K | 388,500 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $6.6K | 1,145,053 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $6.4K | 266,250 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $6.3K | 200,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $6.1K | 850,000 | 0.0% |
| Lipocine Inc New | COM | 53630X104 | $5.7K | 666,666 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $5.5K | 1,081,867 | 0.0% |
| Rockwell Medical Inc | COM | 774374102 | $5.5K | 340,000 | 0.0% |
| Epirus Biopharmaceuticals in | COM | 29428P107 | $5.1K | 896,600 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $5.0K | 397,500 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $4.6K | 499,815 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $4.2K | 68,800 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $4.0K | 361,000 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $3.9K | 189,000 | 0.0% |